The new facility is expected to be operational in 2025.
Insect producer Divaks (Vilnius, Lithuania) has selected technology group Bühler to build its first industrial-scale plant for commercially producing yellow mealworm (Tenebrio molitor). Slated to be operational in 2025, the facility will produce up to 15,000 tons of insect-derived products annually, the firms say.
Divaks has asked Bühler to plan and build the plant and to help organize the supply chain. The 10,000-sq-ft site will be located in Lithuania’s Marijampole Free Economic Zone.
Mealworms are a nutritious protein source that can serve as an alternative to meat and ingredients in product categories like sports nutrition, snacks, confectionery, and pet food. Mealworm protein is also environmentally friendly, and Divaks is furthering its eco-friendliness by using the residue from mealworm production as organic fertilizer.
“Bühler will be responsible for all process technology, which will include feedstock preparation to provide safe, palatable, and nourishing feed to the larvae and a fully automated larvae growth system with sophisticated climate control,” the firms’ press release states. “Furthermore, Bühler will provide the processing line to transform the harvested larvae into textured insect proteins (TIP), insect protein concentrates (IPC), and other specialized food ingredients.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.